Symptoms of Multiple Myeloma
Multiple myeloma presents with a constellation of symptoms primarily characterized by hypercalcemia, renal insufficiency, anemia, and bone lesions (CRAB features), which are the hallmark manifestations of end-organ damage caused by the proliferation of malignant plasma cells. 1, 2
Core Clinical Manifestations (CRAB Features)
Bone Disease
- Bone pain: Most common symptom, particularly affecting the back, ribs, and pelvis 3
- Lytic bone lesions: Present in nearly 80% of patients at diagnosis 4
- Pathologic fractures: Especially vertebral compression fractures leading to height loss
- Severe osteopenia: Can occur even without discrete lytic lesions
Hematologic Abnormalities
- Anemia: Present in approximately 73% of patients 5
- Weakness and fatigue: Common presenting symptoms due to anemia 4
- Increased susceptibility to infections: Due to immune dysfunction
Renal Manifestations
- Renal insufficiency: Present in about 25% of patients at diagnosis (creatinine ≥2 mg/dL) 4
- Primary causes: "Myeloma kidney" (cast nephropathy) and hypercalcemia 4
- Proteinuria: May be present due to light chain excretion
Metabolic Disturbances
- Hypercalcemia: Can lead to:
- Constipation
- Confusion
- Dehydration
- Somnolence
- Coma in severe cases 3
Neurological Manifestations
- Spinal cord compression: Due to vertebral collapse or extramedullary plasmacytomas
- Peripheral neuropathy: Can occur due to amyloid deposition or as a paraneoplastic phenomenon
- Cranial nerve involvement: Particularly affecting II, V, VI, VII, and VIII cranial nerves 3
Less Common Presentations
- Extramedullary plasmacytomas: Soft tissue masses of malignant plasma cells
- Hyperviscosity syndrome: Visual disturbances, neurological symptoms, bleeding
- Amyloidosis: Can present with:
- Macroglossia (10% of cases)
- Nephrotic syndrome
- Congestive heart failure
- Orthostatic hypotension
- Sensorimotor peripheral neuropathy 4
Important Diagnostic Considerations
The diagnosis of symptomatic multiple myeloma requires:
- ≥10% clonal plasma cells in bone marrow or a biopsy-proven plasmacytoma
- Evidence of end-organ damage (CRAB criteria) attributable to the plasma cell disorder 1
CRAB Criteria Defined:
- C: Hypercalcemia (serum calcium >11.5 mg/dL)
- R: Renal insufficiency (serum creatinine >2 mg/dL or creatinine clearance <40 mL/min)
- A: Anemia (hemoglobin <10 g/dL or ≥2 g/dL below lower limit of normal)
- B: Bone lesions (lytic lesions, severe osteopenia, or pathologic fractures) 1, 2
Clinical Pitfalls
Differential diagnosis: CRAB features are not exclusive to multiple myeloma; they can be seen in other conditions like diffuse large B-cell lymphoma 6
Comorbidities in elderly patients: Several conditions can mimic myeloma manifestations:
- Mild renal insufficiency due to diabetes or hypertension
- Anemia due to nutritional deficiencies or chronic disease
- Diffuse osteoporosis due to age or hormonal changes
- Hypercalcemia due to hyperparathyroidism 1
Distinguishing between MGUS, smoldering myeloma, and symptomatic myeloma: Requires careful evaluation of M-protein levels, bone marrow plasma cell percentage, and presence of end-organ damage 1
Multiple myeloma should be suspected in any patient over 60 years with unexplained anemia, renal failure, hypercalcemia, or bone pain, especially when accompanied by an elevated ESR, low albumin/globulin ratio, or unexplained back pain 2.